Search

everythinglearnresearchcommunity

for

Search:↓

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Histone modification is key in treating chronic inflammatory skin diseases.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Vitiligo is a skin condition causing white patches, likely due to an autoimmune issue.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

More research is needed to understand and manage rheumatoid arthritis better.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

PPARα agonists may help treat alopecia areata by reducing inflammation.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

Lupus enteritis is a rare but serious gut inflammation in lupus patients, often hard to diagnose without prior lupus symptoms.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Hair loss requires customized treatments based on its various causes and types.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Brodalumab effectively treated a man's severe hand and foot psoriasis.